BioBanking and Cancer at the Crossroads 2014 | Impact of Biobanks and Fit-for-Purpose Biospecimens

An-Dinh Nguyen interviews Carolyn Compton of National Biomarkers Developmental Alliance, Complex Adaptive Systems Institute, Mayo Medical School and Arizona State University on July 23, 2014. Dr. Compton will be a plenary keynote speaker at the Leaders in Biobanking Congress and Cancer Diagnosis at the Crossroads: Precision Medicine Driving Change event, September 15-17 in Seattle, WA. Topics include effects of pre-analytical variables on human biospecimens during acquisition and processing, the importance of fit-for-purpose samples and how biobanks play a role in making personalized cancer therapies possible.